Cardiome Pharma buys Swiss drug company Correvio in stock and cash deal

VANCOUVER – Cardiome Pharma Corp. (TSX:COM) said Monday it has bought Correvio LLC, a privately held Swiss drug company. Under the deal, Cardiome has agreed to acquire Correvio in exchange for 19.9 per cent of Cardiome’s outstanding shares and US$12 million in deferred cash compensation.

News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Canadian Press

The Canadian Press is Canada's trusted news source and leader in providing real-time, bilingual multimedia stories across print, broadcast and digital platforms.